Device Ophthalmology

Rxsight Light Delivery Device (Ldd)

Payments companies reported to CMS as associated with Rxsight Light Delivery Device (Ldd). "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.

$15Massociated payments (2023-2025)
8,565clinicians with associated payments
1company reporting

By year

2023 $1.9M
2024 $11M
2025 $1.9M

Payments reported as associated with Rxsight Light Delivery Device (Ldd), per program year, as reported to CMS.

Who makes it

Specialties most often involved

Ophthalmology $12M
Ophthalmic Plastic and Reconstructive Surgery $999K
Optometrist $786K
Cornea and External Diseases Specialist $471K
Glaucoma Specialist $52K
Corneal and Contact Management $21K

Where the associated payments went, by the receiving clinician's specialty.

Clinicians most associated with Rxsight Light Delivery Device (Ldd)

These are the largest totals companies reported as associated with Rxsight Light Delivery Device (Ldd). They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.

ClinicianLocationSpecialtyAssociated payments (2023-2025)
Daniel Schwartz San Francisco, CA Ophthalmology $7,852,510.15
Tamara Fountain Deerfield, IL Ophthalmic Plastic and Reconstructive Surgery $993,629.48
Daniel Durrie Overland Park, KS Ophthalmology $934,709.40
Vance Thompson Sioux Falls, SD Ophthalmology $423,450.90
Brian Shafer Plymouth Meeting, PA Cornea and External Diseases Specialist $419,708.86
Stephen Slade Houston, TX Ophthalmology $380,904.06
Nicholas Bruns Flint, MI Optometrist $134,345.33
Frank Bucci Wilkes Barre, PA Ophthalmology $120,298.53
John Doane Leawood, KS Ophthalmology $115,815.68
James Lehmann San Antonio, TX Ophthalmology $114,303.65

Prescribed Rxsight Light Delivery Device (Ldd)?

See what its makers reported for your doctor. Two steps, private, no account.

Check my doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.